特宝生物

688278 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

27.2B ($4.0B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

2.8B

Net Income

828.0M

Gross Margin

N/A

Op. Margin

34.5%

Net Margin

29.4%

ROE

32.4%

ROA

27.1%

D/E

0.19

Dividend Yield

N/A

EPS

2.03

Current Ratio

4.34

Price History

Company Info

Industry	C27医药制造业
Market Segment	STAR Market
Currency	CNY
Fiscal Year	2024

Business Overview

Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally. It offers various drug products, such as pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin; active pharmaceutical ingredients (APIs); and reagents to treat viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is headquartered in Xiamen, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 特宝生物

Ticker	688278
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业